Obstructive sleep apnea-hypopnea syndrome (OSAHS) is characterized by recurrent episodes of partial or complete upper airway obstruction during sleep. This manifests as a reduction in (hypopnea) or complete cessation of (apnea) air flow despite ongoing inspiratory efforts. The lack of adequate alveolar ventilation usually results in oxygen desaturation and, in cases of prolonged events, a gradual increase in PaCO 2 .The events are often terminated by arousals [1] .
Despite increasing numbers of epidemiologic studies reporting sleep-disordered breathing in the general population, a majority of individuals with apneic or hypopneic activity, snoring, and sleepiness are unrecognized by the medical community. The National Commission for Sleep Disorders Research reported finding only 36 International Classification Disease codes for sleep apnea in a 1985 through 1987 administrative database containing approximately 10 million hospital discharges. The rate at which sleep-disordered breathing is being recognized may be increasing. In one managed care setting, between 1991 and 1994, the rates of new patients undergoing sleep studies increased 30% per year, resulting in recognition of approximately 10 to 30% of individuals in the health management organization believed to meet minimal criteria for sleep apneahypopnea syndrome [2] .
Diagnostic criteria for obstructive sleep apnea-hypopnea syndrome
Individuals must fulfill criterion A or B, plus criterion C to be diagnosed with OSAHS [1]:
(A) Excessive daytime sleepiness that is not better explained by other factors. (B) Two or more of the following that are not better explained by other factors:
• 
Sleep apnea
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Respiratory effort related arousal event
A sequence of breaths characterized by increasing respiratory effort leading to an arousal from sleep, but which does not meet criteria for an apnea or hypopnea, defines a respiratory effort related arousal event [1] . It should last 10 seconds or longer and there should be a pattern of progressively more negative esophageal pressure, terminated by a sudden change in pressure to a less negative level and an arousal.
Associated features
The following are features associated with OSAHS [1]: 
Differential diagnosis
A case of OSAHS should be differentiated from the following [1]:
(1) Simple snoring. This is associated with few episodes of air flow obstruction and no symptoms of disruptive sleep or impaired daytime performance.
(2) Chronic hypoventilation syndrome. OSAHS may be present in some patients with an elevated awake PaCO 2 but is distinguished from chronic hypoventilation syndrome by the failure of PaCO 2 to return to normal after relief of upper airway obstruction with continuous positive airway pressure.
(3) Central sleep apnea and Cheyne-Stokes respiration. OSAHS has continued respiratory efforts but these two conditions do not.
Sleepiness should not be considered a diagnostic feature if it can be attributed to narcolepsy, insufficient sleep, periodic leg movements, or nonrespiratory arousal disorders, or alcohol and drug use [1] .
Although sleep-disordered breathing is increasingly recognized, it is important that recognition strategies develop appropriately and optimize the use of available resources for diagnosis and treatment [2] .
A disparity between community prevalence of chronic disease and clinical recognition is not uncommon, but the large disparity between the community prevalence of sleep-disordered breathing and its recognition in the patient group is. We suspect the reasons relate to deficiencies in recognition among primary care providers and, perhaps, among specialists. The stereotype of the sleep-disordered breathing patient is the obese, middle-aged man, but the illness occurs at all ages, in both genders, and in nonobese as well as obese people. The areas that appear particularly problematic include recognition of disorder in thin individuals, in the elderly, in women, and perhaps in children (especially African-American children). Clinical underrecognition of sleep-disordered breathing appears to be partly based on under-reporting of symptoms of snoring and apnea in women compared with men, and possibly because of preferential reporting of fatigue rather than sleepiness [2] .
Sleep-disordered breathing may be particularly prevalent but difficult to recognize in individuals with pulmonary dysfunction (eg, chronic obstructive pulmonary disease, bronchitis, asthma) or heart failure. In such subjects, symptoms of underlying diseases may cause nocturnal breathing problems and sleep interruption, masking symptoms of sleep-disordered breathing. Likewise, people with diabetes and central body fat may be at risk for sleep-disordered breathing. The frequent occurrence of fatigue and frequency of underlying medical problems in these patients, however, may distract from sleep-disordered breathing evaluations. Subjects who recently experienced myocardial infarction or stroke also appear to have increased apneic activity. Individuals with underlying comorbidities also may be especially vulnerable to the end organ effects of recurrent hypoxemia and sleep fragmentation that occurs with sleep apnea-hypopnea syndrome. Although clinical trial data are not yet available regarding the role of aggressive interventions in these patient groups, it is likely that careful and prudent evaluation of sleep pathology might lead to better integrated health care for them [2] .
Physical examination
Physical examination has not proved to be very helpful in identifying patients with sleep-disordered breathing. One study suggested that a routine upper airway examination for obvious pharyngeal crowding and tonsillar hypertrophy is helpful, but a recent study demonstrated that experienced sleep physicians had limited ability to predict sleep-disordered breathing based on the patient's history and physical examination. In fact, their clinical impression had only 50 to 60% sensitivity and 63 to 70% specificity [2] .
Body mass index (BMI) and neck circumference as indicators of obesity have been shown in more than one study to have good predictive power for OSAHS. Neck circumference is measured at the cricothyroid membrane [3] . In general, men with a neck circumference of 17 inches or greater and women with a neck circumference of 16 inches or greater are at risk for OSAHS. There is controversy in the literature, however, regarding whether neck circumference is independent of BMI as a predictor of obstructive sleep apnea. The type of obesity (truncal or peripheral) may also be important; upper body obesity may be associated with a higher risk of obstructive sleep apnea. BMI is the variable most frequently used in clinical practice as a predictor of OSAHS. Obesity has been defined as a BMI value greater than or equal to 27.8 for men and 27.3 for women. One third of the population of the United States is obese by this criterion and at higher risk for OSA [3] . Recently, using questionnaires completed by patients, it was shown that combining BMI (< 28), Epworth Sleepiness Scale score (< 2), and the absence of observed apnea may be helpful in predicting patients with low (< 20 In obese patients referred to a respiratory sleep laboratory and evaluated by clinical score, pulmonary function tests, arterial blood gases, and oximetry, no individual sign or symptom can accurately predict the presence or absence of OSAHS. Provided that it is validated in prospective studies, a logistic regression model using these variables may be useful for the prediction of OSAHS [5].
Sleep studies: polysomnography
Polysomnography is considered the gold standard for the diagnosis of sleep apnea and other sleep disorders. It involves an overnight sleep in the laboratory with multichannel monitoring of multiple physiologic variables with the attendance of a technician throughout the study. In the analysis of the study, the number of apneas per hour is expressed the apnea index, which determines the severity of OSAHS. Although polysomnography is the most widely accepted test for the diagnosis of sleep-disordered breathing, it is important to realize that patients with OSAHS (especially mild cases) may have substantial night-to-night variability, which raises the possibility of missing the diagnosis of the disorder. Therefore, a negative first-night study finding is insufficient to rule out OSAHS in patients with a high clinical suspicion of the disease. Polysomnography can detect arousals in patients with upper airway resistance syndrome (UARS) but may not confirm the diagnosis. To confirm the diagnosis, an intraesophageal catheter may be required to demonstrate that arousals are associated with a marked decrease in intrathoracic pressure associated with the narrowing of the upper airway [4].
Types of sleep studies
A level I study is the complete study performed in the laboratory and includes monitoring of the following: The electroencephalogram, electrooculogram, and electromyogram are the standard recordings used for assessing sleep state versus awake state and for determining the levels of sleep. To determine the index of apneic events, it must be known whether the patient is asleep and for how long the patient is asleep [6] .
A level II study is a complete nonattended home study. It measures the same parameters as a level I study and may use heart rate in lieu of an electrocardiographic tracing. This study allows for the characterization of the same measures as the level I study and is perhaps more cost effective. It also allows for a more natural environment for the patient to measure sleep and, therefore, to be more accurate. One of the biggest problems with these studies is that should there be a technical problem such as a lead falling off, the data are lost and the study may have to be repeated. Various steps have been taken against this, such as monitoring of the study through modems that would alert a hospital-based technician so that a phone call could be made to correct the problem [6] .
Level III studies are partial home studies that usually include some type of cardiorespiratory measure for air flow and respiratory effort, oximetry, pulse rate, and sleep positioning. They allow for the detection of the central and obstructive events, desaturations, bradyarrythmias and tachyarrythmias, and position changes. Because fewer parameters are being measured and fewer wires are being used, there is a lower likelihood that there will be detachment of a lead. The disadvantages of these studies are that no information is generated regarding limb movements, sleep stage related apnea, arrythmias, or frequencies of arousals associated with the sleep disturbance. Because there is no information generated regarding sleep stages, the amount of sleep time must be estimated [6] .
Level IV studies are very limited home studies or screening tools and measure only one or two parameters such as pulse rate and oximetry. The advantage is that these are much less expensive and allow for the measure of oximetry, which is one of the key parameters one wishes to measure in a sleep disorder. The disadvantage is that these studies have low sensitivity as a screening tool and can miss mild to moderate obstructive sleep disorders. They also do not have the ability to diagnose any other type of sleep disorder [6] .
The American Sleep Disorder Association has set forth its recommendations for portable or unattended recordings. In summary, their recommendations are that standard polysomnography is the accepted test for the diagnosis and determination of the severity and treatment of obstructive sleep apnea. Unattended recordings are an acceptable alternative only when the following conditions are met:
(1) Clinical symptoms are severe and indicative of sleep apnea, and the initiation of treatment is urgent and standard polysomnography is not readily available.
(2) If the patient cannot be studied in the sleep laboratory.
(3) For follow-up studies when the diagnosis has been previously established and therapy initiated to evaluate response to therapy.
In the technical recommendations the American Sleep Disorder Association feels that:
(1) Only level II and III studies are acceptable for the diagnosis and assessment of therapy for sleep apnea. Level IV studies are not acceptable.
(2) The body position must be documented.
(3) The portable devices record raw, unprocessed data, and the stored data must be reproducible. Computer analysis is acceptable only when used as an aid to interpretation along with visual inspection of the entire raw data record [6] .
It is often seen that during rapid eye movement (REM) sleep, apneic events are more common and often of a greater duration, with potentially more serious oxygen desaturation, than in other periods of sleep. Therefore, it is imperative that one be able to determine whether the patient has entered into a REM episode, and the presence of significant sleep apnea cannot be ruled out unless the polysomnogram includes REM sleep.
The evaluation of breathing requires measure of air flow, as well as respiratory movement. Nasal or oral air flow can be measured with a thermistor or heat sensor. An infrared CO 2 analyzer may also be used. The detection of respiratory movements along with air flow is needed to determine obstructive from central apnea and to reliably detect partial airway obstruction. Most laboratories use thoracic or abdominal gauges, inductive plethysmography, or impedance pneumography to detect respiratory movement. These techniques do not measure respiratory effort, however, and the best method to determine respiratory effort is believed to be an esophageal balloon.
Sleeping position also can have a significant impact on apneic events and oxygen desaturation associated with these events. Patients may have little or no apnea while lying on their side; when they turn into a supine position, however, gravity will have its maximal effect on the soft tissues of the palate and tongue, and significant apnea may ensue. One, should, therefore, assess obstructive phenomena and desaturations in both lateral and supine positions. If the patient normally does not sleep in a supine position, he or she should be encouraged to do so during some portion of the study [6] .
Future trends
Since its inception, the polysomnogram has been the gold standard for the diagnosis of obstructive breathing disorders. The technology used, however, is cumbersome, expensive, and time consuming. A tremendous amount of effort has been put into developing unattended studies that will have the same diagnostic and therapeutic value as the level I polysomnogram. Most people working with sleep disorders today predict that by 2001, approximately 80% of the sleep studies will be performed in the home and nonattended, which will make the study easier for the patients and physicians and also bring costs down and achieve results in a more timely fashion [6] .
There has been a raging debate between proponents of home studies and proponents of in-laboratory full polysomnography, with each side proposing that its technology represents the "best test." Proponents of home studies have claimed that a larger number of patients could be better served by being studying at home at a potentially reduced cost. Advocates of inlaboratory full polysomnography have claimed that these studies provide a greater amount of information. In addition, they allow a technician to be available to adjust signals, potentially start nasal continuous positive airway pressure if the patient meets the criteria for a split-night study, and intervene if the patient has a medical problem. Part of the problem in this debate is that there is probably no single best test. Choosing the best test should be based on pretest clinical suspicion for disease. Practitioners of sleep medicine have to be confident that the technology answers the clinical question being posed. In addition, studies need to assess whether home technology actually allows for the assessment of a greater number of patients at a reduced cost. Specifically, we need to assess not only the cost of a single test, but whether there is any additional cost incurred because of equipment failure or because the initial study failed to answer the underlying clinical question [7] . Twenty-five studies of portable monitoring devices were reviewed and reliability in unattended home use, equipment failure rates, night-to-night reproducibility, price, compliance, and safety are rarely reported. All sleep monitoring systems that are proposed as prequalifiers or replacement for polysomnography must be validated in the setting in which they are intended to be used [8] .
Why sleep apnea should be diagnosed and treated
There is compelling evidence in the literature to support treating sleep apnea. It is well documented that OSAHS is associated with and can aggravate many medical illnesses. OSAHS patients with an apnea index of more than 20 have increased mortality. Treatment with nasal continuous positive airway pressure has been shown to improve survival compared with conservative treatment. Patients with sleep apnea may have some cognitive impairment, manifesting as deficits in thinking, perception, memory, and communication. Depression is also more prevalent in patients with OSAHS. They are also at high risk of industrial and automobile accidents. Treatment improves most of the aforementioned derangements. It therefore is widely accepted that appropriate treatment of sleep apnea can improve morbidity, mortality, and quality of life of patients [4] .
Central sleep apnea-hypopnea syndrome
Idiopathic central sleep apnea-hypopnea syndrome is characterized by recurrent apneic episodes in the absence of upper airway obstruction during sleep, which usually results in oxygen desaturation, recurrent arousals, and daytime symptoms. It is believed that individuals with this disorder may have increased ventilatory response to CO 2 that causes them to hyperventilate and become hypocapneic. This results in their PCO 2 being closer to the sleep-induced PCO 2 apnea threshold that results from withdrawal of the wakefulness stimulus to respiration [1].
Diagnostic criteria
The individual must fulfill criteria A, B, and C to be diagnosed with central sleep apnea-hypopnea syndrome.
(A) At least one of the following symptoms that is not better explained by other factors:
•Excessive daytime sleepiness •Frequent nocturnal arousals/awakenings (B) Overnight monitoring demonstrates five or more central apneic events plus hypopneic events per hour of sleep. (C) Normocarbia while awake (PaCO 2 < 45 torr).
A central apnea-hypopnea event is characterized by reduced or absent breathing and respirator efforts with reduction of air flow and esophageal pressure and lasting 10 seconds or longer.
Cheyne-Stokes breathing syndrome
Cheyne-Stokes breathing syndrome [1] is characterized by a cyclical fluctuation in breathing with periods of central apneas or hypopneas alternating with periods of hyperpnea in a gradual waxing and waning fashion. It occurs in patients with cardiac dysfunction, usually in association with severe congestive heart failure or neurologic disease or dysfunction, usually cerebrovascular. It is present during sleep and in severe cases may also be observed during wakefulness.
Diagnostic criteria
The individual must fulfill criteria A and B to be diagnosed with Cheyne-Stokes breathing syndrome:
